Wouldn't blame anyone selling any stock in frustration, or more...

Wouldn't blame anyone selling any stock in frustration, or more sensibly selling out of OCC on yet another announcement spike that fails to hold (not uncommon in the micro cap realm) if unconvinced by the business progress, but selling out just before its about to announce qtrly Striate sales numbers that now going to include Ace Southern (marketed as perFORM therein) and Henry Schein marketing of Striate as well as over a year of BioHorizons that have unequivocally grown and the third quarter of high margin Remplir in Oz.........hmmm let me have a think about the cognitive dissonance on that one?

Thanks for your bit of stock though, whoever you are. Lets just have a little look at the last qtrly sales release, up 71% YoY (and accrual revenue is recognised linearly):


Obviously there is a little lumpiness in sales and lag as the year long BH marketing takes effect, hence I tend to smooth out with a commonly trailed yearly total: